Nabarro advises Numis on £25.5m placing to raise additional capital for Retroscreen
Nabarro is advising existing client Numis Securities on a £25.5m placing to raise additional capital for AIM-traded Retroscreen Virology.
Retroscreen conducts research into antiviral drugs and vaccines through the use of its ‘Viral Challenge Model’, which involves infecting healthy human volunteers with a virus under controlled conditions.
The Nabarro team advising Numis in its capacity as nomad and broker for Retroscreen was led by corporate partner Alasdair Steele, assisted by senior associate Jack Shepherd and trainee Nikita Arora.
News from Nabarro
Briefings from Nabarro
Nabarro partner Martin McKervey shares his thoughts on unlocking export growth.
The changes proposed by the HSE in the new draft CDM regulations are underpinned by a desire to improve standards of health and safety, particularly on smaller construction sites.
Analysis from The Lawyer
Clients are more willing to bring claims against professional service providers but the risk to defendants is not as dramatic as it might seem
Real estate continues to be the key money spinner for Nabarro, which has always been known for its work in the UK property market, (although) last year results were up across the firm. Google’s ...